Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2010 (2010), Article ID 340168, 10 pages
http://dx.doi.org/10.1155/2010/340168
Research Article

Blockade of NR2A-Containing NMDA Receptors Induces Tau Phosphorylation in Rat Hippocampal Slices

1Département de chimie-biologie, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada G9A 5H7
2Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

Received 8 December 2009; Accepted 23 February 2010

Academic Editor: Lin Xu

Copyright © 2010 Julie Allyson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Komuro and P. Rakic, “Modulation of neuronal migration by NMDA receptors,” Science, vol. 259, no. 5104, pp. 95–97, 1993. View at Google Scholar · View at Scopus
  2. R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis, “The glutamate receptor ion channels,” Pharmacological Reviews, vol. 51, no. 1, pp. 7–61, 1999. View at Google Scholar · View at Scopus
  3. R. Balazs, O. S. Jorgensen, and N. Hack, “N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture,” Neuroscience, vol. 27, no. 2, pp. 437–451, 1988. View at Google Scholar · View at Scopus
  4. S. A. Lipton and P. A. Rosenberg, “Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders,” The New England Journal of Medicine, vol. 330, no. 9, pp. 613–622, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. D. W. Choi, “Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage,” Trends in Neurosciences, vol. 11, no. 10, pp. 465–469, 1988. View at Google Scholar · View at Scopus
  6. S. Papadia and G. E. Hardingham, “The dichotomy of NMDA receptor signaling,” Neuroscientist, vol. 13, no. 6, pp. 572–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. G. E. Hardingham and H. Bading, “The Yin and Yang of NMDA receptor signalling,” Trends in Neurosciences, vol. 26, no. 2, pp. 81–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Hetman and G. Kharebava, “Survival signaling pathways activated by NMDA receptors,” Current Topics in Medicinal Chemistry, vol. 6, no. 8, pp. 787–799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Ikonomidou, F. Bosch, M. Miksa et al., “Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain,” Science, vol. 283, no. 5398, pp. 70–74, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Sutton, H. T. Ito, P. Cressy, C. Kempf, J. C. Woo, and E. M. Schuman, “Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis,” Cell, vol. 125, no. 4, pp. 785–799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Fiumelli, I. M. Riederer, J.-L. Martin, and B. M. Riederer, “Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape,” Cell Motility and the Cytoskeleton, vol. 65, no. 6, pp. 495–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Baird, E. Trenkner, and C. A. Mason, “Arrest of afferent axon extension by target neurons in vitro is regulated by the NMDA receptor,” Journal of Neuroscience, vol. 16, no. 8, pp. 2642–2648, 1996. View at Google Scholar · View at Scopus
  13. E. M. Quinlan and S. Halpain, “Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors,” Neuron, vol. 16, no. 2, pp. 357–368, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Fleming and G. V. W. Johnson, “Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP,” Biochemical Journal, vol. 309, no. 1, pp. 41–47, 1995. View at Google Scholar · View at Scopus
  15. J.-Z. Wang and F. Liu, “Microtubule-associated protein tau in development, degeneration and protection of neurons,” Progress in Neurobiology, vol. 85, no. 2, pp. 148–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Burack and S. Halpain, “Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons,” Neuroscience, vol. 72, no. 1, pp. 167–184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal, “Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target,” Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 31825, 11 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-X. Gong and K. Iqbal, “Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease,” Current Medicinal Chemistry, vol. 15, no. 23, pp. 2321–2328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Köhr, “NMDA receptor function: subunit composition versus spatial distribution,” Cell and Tissue Research, vol. 326, no. 2, pp. 439–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Berberich, V. Jensen, Ø. Hvalby, P. H. Seeburg, and G. Köhr, “The role of NMDAR subtypes and charge transfer during hippocampal LTP induction,” Neuropharmacology, vol. 52, no. 1, pp. 77–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Wenzel, J. M. Fritschy, H. Mohler, and D. Benke, “NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins,” Journal of Neurochemistry, vol. 68, no. 2, pp. 469–478, 1997. View at Google Scholar · View at Scopus
  22. S. Cull-Candy, S. Brickley, and M. Farrant, “NMDA receptor subunits: diversity, development and disease,” Current Opinion in Neurobiology, vol. 11, no. 3, pp. 327–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, P. W. Tak, M. Aarts et al., “NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo,” Journal of Neuroscience, vol. 27, no. 11, pp. 2846–2857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. C. Anastasio, Y. Xia, Z. R. O'Connor, and K. M. Johnson, “Differential role of N-methyl-d-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits,” Neuroscience, vol. 163, no. 4, pp. 1181–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-A. Martel, D. J. A. Wyllie, and G. E. Hardingham, “In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death,” Neuroscience, vol. 158, no. 1, pp. 334–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Fischer, V. Mutel, G. Trube et al., “Ro 25-6981, a highly potent and selective blocker of N-methyl-D- aspartate receptors containing the NR2B subunit. Characterization in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 283, no. 3, pp. 1285–1292, 1997. View at Google Scholar · View at Scopus
  27. R. A. Hall, A. Hansen, P. H. Andersen, and T. R. Soderling, “Surface expression of the AMPA receptor subunits GluR1, GluR2, and GluR4 in stably transfected baby hamster kidney cells,” Journal of Neurochemistry, vol. 68, no. 2, pp. 625–630, 1997. View at Google Scholar · View at Scopus
  28. T. F. Gendron and L. Petrucelli, “The role of tau in neurodegeneration,” Molecular Neurodegeneration, vol. 4, no. 1, article 13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Nishimura, Y. Yang, and B. Lu, “PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila,” Cell, vol. 116, no. 5, pp. 671–682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. G.-I. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S.-I. Hisanaga, “Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 17166–17172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. M.-S. Lee, Y. T. Kwon, M. Li, J. Peng, R. M. Friedlander, and L.-H. Tsai, “Neurotoxicity induces cleavage of p35 to p25 by calpain,” Nature, vol. 405, no. 6784, pp. 360–364, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. D.-H. Cho, J. Seo, J.-H. Park et al., “Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116,” Hypertension, vol. 55, no. 2, pp. 345–352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.-X. Gong, “Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation,” European Journal of Neuroscience, vol. 22, no. 8, pp. 1942–1950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. V. J. De-Paula, E. L. Schaeffer, L. L. Talib, W. F. Gattaz, and O. V. Forlenza, “Inhibition of phospholipase A2 increases Tau phosphorylation at Ser214 in embryonic rat hippocampal neurons,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 1, pp. 57–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. N. C. Anastasio and K. M. Johnson, “Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat,” Journal of Neurochemistry, vol. 104, no. 5, pp. 1210–1218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Sircar, P. Follesa, and M. K. Ticku, “Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex,” Molecular Brain Research, vol. 40, no. 2, pp. 214–220, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Zhou and M. Baudry, “Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors,” Journal of Neuroscience, vol. 26, no. 11, pp. 2956–2963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Groc, M. Heine, S. L. Cousins et al., “NMDA receptor surface mobility depends on NR2A-2B subunits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 49, pp. 18769–18774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. D. Weingarten, A. H. Lockwood, S. Y. Hwo, and M. W. Kirschner, “A protein factor essential for microtubule assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 5, pp. 1858–1862, 1975. View at Google Scholar · View at Scopus
  40. D. W. Cleveland, S. Y. Hwo, and M. W. Kirschner, “Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly,” Journal of Molecular Biology, vol. 116, no. 2, pp. 227–247, 1977. View at Google Scholar · View at Scopus
  41. N. Shahani and R. Brandt, “Functions and malfunctions of the tau proteins,” Cellular and Molecular Life Sciences, vol. 59, no. 10, pp. 1668–1680, 2002. View at Google Scholar · View at Scopus
  42. P. S. Yamauchi and D. L. Purich, “Microtubule-associated protein interactions with actin filaments: evidence for differential behavior of neuronal MAP-2 and tau in the presence of phosphatidyl-inositol,” Biochemical and Biophysical Research Communications, vol. 190, no. 3, pp. 710–715, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. S. C. Selden and T. D. Pollard, “Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments,” Journal of Biological Chemistry, vol. 258, no. 11, pp. 7064–7071, 1983. View at Google Scholar · View at Scopus
  44. R. Brandt, J. Léger, and G. Lee, “Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain,” Journal of Cell Biology, vol. 131, no. 5, pp. 1327–1340, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Maas, J. Eidenmüller, and R. Brandt, “Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments,” Journal of Biological Chemistry, vol. 275, no. 21, pp. 15733–15740, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. S. M. Jenkins and G. V. W. Johnson, “Tau complexes with phospholipase C-γ in situ,” NeuroReport, vol. 9, no. 1, pp. 67–71, 1998. View at Google Scholar · View at Scopus
  47. G. Lee, S. T. Newman, D. L. Gard, H. Band, and G. Panchamoorthy, “Tau interacts with src-family non-receptor tyrosine kinases,” Journal of Cell Science, vol. 111, no. 21, pp. 3167–3177, 1998. View at Google Scholar · View at Scopus
  48. H. Liao, Y. Li, D. L. Brautigan, and G. G. Gundersen, “Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau,” Journal of Biological Chemistry, vol. 273, no. 34, pp. 21901–21908, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Sontag, V. Nunbhakdi-Craig, G. Lee, G. S. Bloom, and M. C. Mumby, “Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A,” Neuron, vol. 17, no. 6, pp. 1201–1207, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Agarwal-Mawal, H. Y. Qureshi, P. W. Cafferty et al., “14-3-3 connects glycogen synthase kinase-3ß to tau within a brain microtubule-associated tau phosphorylation complex,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 12722–12728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. C. H. Reynolds, C. J. Garwood, S. Wray et al., “Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase C?1, Grb2, and Src family kinases,” Journal of Biological Chemistry, vol. 283, no. 26, pp. 18177–18186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. I. E. Vega, E. E. Traverso, Y. Ferrer-Acosta et al., “A novel calcium-binding protein is associated with tau proteins in tauopathy,” Journal of Neurochemistry, vol. 106, no. 1, pp. 96–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Zhang, Q. Tian, Q. Zhang, X. Zhou, S. Liu, and J.-Z. Wang, “Hyperphosphorylation of microtubule-associated tau protein plays dual role in neurodegeneration and neuroprotection,” Pathophysiology, vol. 16, no. 4, pp. 311–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. C.-A. Maurage, N. Sergeant, M.-M. Ruchoux, J.-J. Hauw, and A. Delacourte, “Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology,” Acta Neuropathologica, vol. 105, no. 2, pp. 89–97, 2003. View at Google Scholar · View at Scopus
  55. X. Bi, T. S. Haque, J. Zhou et al., “Novel cathepsin D inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus,” Journal of Neurochemistry, vol. 74, no. 4, pp. 1469–1477, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Bi, A. P. Yong, J. Zhou, C. E. Ribak, and G. Lynch, “Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8832–8837, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. S. W. Y. Tsang, H. V. Vinters, J. L. Cummings, P. T.-H. Wong, C. P. L.-H. Chen, and M. K. P. Lai, “Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease,” Neurobiology of Aging, vol. 29, no. 10, pp. 1524–1532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Li, T. H. Murphy, M. R. Hayden, and L. A. Raymond, “Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease,” Journal of Neurophysiology, vol. 92, no. 5, pp. 2738–2746, 2004. View at Publisher · View at Google Scholar · View at Scopus